Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | DRD2 | P14416 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | BCHE | P06276 | 3/20 | 0.35 |
| ▸ | ACHE | P22303 | 3/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24733112 | 1.00 | POLB (0.36) | POLBMAPTDRD2KMT2ABCHE | |
| SCHEMBL27213626 | 0.91 | POLB (0.40) | POLBMAPTKMT2ABCHEACHE | |
| SCHEMBL24732885 | 0.89 | TSHR (0.38) | MAPTKMT2AHRH3 | |
| SCHEMBL24732683 | 0.87 | MEN1 (0.36) | MAPTKMT2ABCHEACHEHRH3 | |
| SCHEMBL30947353 | 0.87 | MEN1 (0.36) | MAPTKMT2ABCHEACHEHRH3 | |
| SCHEMBL24732772 | 0.87 | CYP2D6 (0.38) | MAPTKMT2A | |
| SCHEMBL24732845 | 0.86 | CACNA1B (0.34) | MAPT | |
| SCHEMBL24732916 | 0.85 | TLR7 (0.39) | MAPT | |
| SCHEMBL30947335 | 0.85 | TLR7 (0.39) | MAPT | |
| SCHEMBL24732866 | 0.85 | PTGDR (0.35) | HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240150346-A1 | CLASS OF HETEROAROMATIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | INNOVSTONE THERAPEUTICS LIMITED (CN) | 2024-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240150346-A1 | CLASS OF HETEROAROMATIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | TLR7, TLR1, TLR8 | POLB 2806/4885MAPT 4042/4885DRD2 2701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.